PolyPid to Report First Quarter 2021 Financial Results and Operational Highlights on May 12, 2021

PETAH TIKVA, Israel, April 29, 2021 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today announced that it will report its first quarter 2021 financial